MNKD

MannKind Corporation News Headlines

$6.52
*  
0.30
4.4%
Get MNKD Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading MNKD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Analysts Weigh In On MannKind Following Q4 Results
2/28/2015 8:32:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
2/27/2015 4:00:00 PM - Seeking Alpha


MannKind's Financial Statements Can Be Scary To Most Investors
2/27/2015 10:27:00 AM - Seeking Alpha


How To Beat The Herd Mentality: Highline's Michael Higgins
2/26/2015 3:29:00 PM - Seeking Alpha


An Objective, We Think, Up-To-Date Look At MannKind
2/26/2015 2:17:00 PM - Seeking Alpha


More Insight Into MannKind's Near-Term Profitability
2/25/2015 3:25:00 PM - Seeking Alpha


MannKind Is Tripling Production To Meet Future Demand
2/25/2015 10:46:00 AM - Seeking Alpha


MannKind: Another Year Of Disappointments?
2/25/2015 8:52:00 AM - Seeking Alpha


MannKind Corp. To Present At The RBC Capital Conference; Webcast At 9:00 AM ET
2/25/2015 8:00:00 AM - RTT News


MannKind Q4 14 Earnings Conference Call At 5:00 PM ET
2/24/2015 3:00:00 PM - RTT News


MannKind Investors, Hold On For The Long Haul
2/24/2015 8:25:00 AM - Seeking Alpha


Genetic Technologies Remains Among Most Difficult To Borrow Names
2/24/2015 1:46:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
2/20/2015 4:00:00 PM - Seeking Alpha


Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
2/20/2015 9:00:00 AM - Seeking Alpha


No MannKind Buyout Until Afrezza Is Profitable
2/17/2015 5:04:00 PM - Seeking Alpha


Short Sellers Eye Genetic Tech
2/10/2015 2:58:00 PM - Seeking Alpha


MannKind Investors: Don't Screw Up The Afrezza Launch
2/10/2015 10:50:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Questioning Gilead, MannKind To Market, And More
2/6/2015 4:00:00 PM - Seeking Alpha


What MannKind Investors Can Learn From The Sanofi Conference Call
2/5/2015 2:37:00 PM - Seeking Alpha


Could MannKind's U.S. Traction Result In A Short Squeeze?
2/4/2015 8:59:00 AM - Seeking Alpha


My Well-Valued Growth Portfolio Beats The S&P 500 For January
2/4/2015 7:46:00 AM - Seeking Alpha


AMGN's Biosimilar Matches Blockbuster, PFE Gets FDA Nod, LGND Does A Deal
2/4/2015 12:12:00 AM - RTT News


Sanofi And MannKind Say Inhaled Insulin Afrezza Now Available In U.S.
2/3/2015 1:59:00 AM - RTT News


Sanofi, Mannkind Put Inhaled Insulin Afrezza on US Market
2/3/2015 1:36:00 AM - Dow Jones Business News


Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
1/30/2015 4:00:00 PM - Seeking Alpha